第一作者机构:[1]Beijing Key Lab Pediat Hematol Oncol, Hematol Ctr, Hematol Dis Lab, Beijing 100045, Peoples R China[2]Capital Med Univ, Natl Key Discipline Pediat, Beijing 100045, Peoples R China[3]Minist Educ, Key Lab Major Dis Children, Beijing 100045, Peoples R China[4]Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst, Beijing 100045, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Beijing Key Lab Pediat Hematol Oncol, Hematol Ctr, Hematol Dis Lab, Beijing 100045, Peoples R China[2]Capital Med Univ, Natl Key Discipline Pediat, Beijing 100045, Peoples R China[3]Minist Educ, Key Lab Major Dis Children, Beijing 100045, Peoples R China[4]Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst, Beijing 100045, Peoples R China[5]Beijing Key Lab Pediat Hematol Oncol, Hematol Ctr, Beijing, Peoples R China[6]Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China[7]Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Ctr Clin Epidemiol & Evidence Based Med, Beijing 100045, Peoples R China[8]Shanxi Bethune Hosp, Dept Clin Lab, Taiyuan 030032, Peoples R China
推荐引用方式(GB/T 7714):
Li Na,Yang Ying,Gong Zhihua,et al.Specific Clinical Indicators and Treatment Regimen study of Febrile Children with Langerhans cell Histiocytosis[J].PEDIATRIC BLOOD & CANCER.2022,69:S15-S15.
APA:
Li, Na,Yang, Ying,Gong, Zhihua,Lian, Hongyun,Ma, Honghao...&Zhang, Rui.(2022).Specific Clinical Indicators and Treatment Regimen study of Febrile Children with Langerhans cell Histiocytosis.PEDIATRIC BLOOD & CANCER,69,
MLA:
Li, Na,et al."Specific Clinical Indicators and Treatment Regimen study of Febrile Children with Langerhans cell Histiocytosis".PEDIATRIC BLOOD & CANCER 69.(2022):S15-S15